🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sarcopenia and Interlaminar Epidural Steroid Injection Outcomes in Lumbar Spinal Stenosis

Recruitingn/aAges 50 Years - 75 YearsAllMarmara University
NCT07855419 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational study aims to investigate the association between sarcopenia and clinical outcomes following interlaminar epidural steroid injection in patients with lumbar spinal stenosis. Patients who are scheduled to undergo interlaminar epidural steroid injection as part of routine clinical care will be enrolled. Before the procedure, sarcopenia-related assessments, including the SARC-F questionnaire, handgrip strength, and the five-times sit-to-stand test, will be performed. Lumbar magnetic resonance imaging (MRI) will also be evaluated for paraspinal muscle characteristics and the severity of lumbar spinal stenosis. Pain intensity, functional status, walking capacity, and health-related quality of life will be assessed at baseline. Pain intensity, functional status, and health-related quality of life will be reassessed at 3 weeks and 3 months after the procedure. T

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical and radiological diagnosis of lumbar spinal stenosis * Persistent symptoms despite conservative treatment and scheduled to undergo interlaminar epidural steroid injection as part of routine clinical care * Age between 50 and 75 years * Low back and/or leg pain for at least 3 months * Availability of lumbar magnetic resonance imaging (MRI) Exclusion Criteria: * History of lumbar fusion surgery * Lumbar epidural steroid injection within the previous 3 months * Prominent radiculopathy due to lumbar disc herniation * Severe motor deficit or an indication for surgical treatment * Polyneuropathy, neuromuscular disease, or neurological disease that may significantly affect muscle mass * Active malignancy or systemic inflammatory disease * Significant mobility limitation due to advanced hip or knee osteoarthritis * Cognitive impairment or communication problems that may prevent completion of study assessments * Coagulopathy or active infection constituting a contraindication to epidural injection * Inflammatory rheumatic disease requiring chronic corticosteroid therapy
💊

What it tests

  • Not listed
📍

Where

1 site
Marmara University Pendik Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy